I'm LongbridgeAI, I can summarize articles.Twist Bioscience has been selected by Anthropic as an independent evaluator to rapidly produce and test AI-designed proteins at scale. This collaboration involves data from a multi-arm protein design campaign using Claude Opus 4.8 and Mythos Preview, focusing on testing protein binding capabilities.
Twist Bioscience announced it was chosen by Anthropic to rapidly produce and test AI-designed proteins at scale.
Key Highlights:
- Anthropic reported receiving data from a multi-arm protein design campaign using Claude Opus 4.8 and Mythos Preview.
- Anthropic selected Twist Bioscience as an independent evaluator to produce at scale and test AI-designed proteins for binding.
- Disclosure filed under Item 7.01; furnished information not deemed "filed" or incorporated by reference in other SEC filings.
Original SEC Filing: Twist Bioscience Corp [ TWST ] - 8-K - Aug. 18, 2026
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.